Biomimetic nanoparticles, such as neutrophil membrane-coated poly(lactic-co-glycolic acid) (PLGA) nanoparticles, reduce immunogenicity and improve targeting, achieving 3-fold higher joint accumulation (19)
Potential contributors may include a possibility of higher drug exposure in lower BMI classes, although other explanations, including differences in motivation and cultural mores regarding body size, cannot be excluded. More studies needed on physiology The researchers said adults with a BMI of 30 kg/m 2 or less lost less weight than those with a higher BMI and hypothesized that those adults may have had a lower percentage weight loss as they may be closer to reaching a set point where their weight is in harmony with the genetic and environmental determinants of body weight and adiposity. The cardiometabolic benefits of weight loss are driven by reduction in the abnormal ectopic and visceral depots of fat, not by reduction of subcutaneous fat stores in the hips and thighs, the researchers wrote
Verrillo, E
Wegovy (semaglutide), on the other hand, is approved for chronic weight management in adults and children aged 12 and older
Clinical trials demonstrate that people using semaglutide lose an average of 15% of body weight over one year when combined with lifestyle changes
Supplementing glutathione and other antioxidants is yet another strategy
